Pentermise Tablets (Phentermine Hydrochloride)

Adult dose

Adults: Administer 37.5 mg of phentermine hydrochloride orally once daily, before breakfast or 1 ～ 2 hours after breakfast. Use the minimum effective dose, adjusting it individually to achieve an appropriate response. A dose of 18.75 mg once daily may be appropriate for some patients, while in some cases it may be preferable to take 18.75 mg twice daily. Avoid taking this medicine late at night because it may cause insomnia. This medicine should be administered for a short period (within 4 weeks). However, to reduce the risk of inappropriate use, treatment with this medicine may be continued if the patient achieves satisfactory weight loss within the first 4 weeks (weight loss of at least 1.8 kg or weight loss considered satisfactory by both the physician and the patient).

This medication should not be used in conjunction with other appetite suppressants and should only be used alone for a short period. It is not recommended to take this medication with other drugs for weight loss. If symptoms such as shortness of breath, chest pain, fainting, or leg swelling occur, the doctor should be notified immediately, and medication use should be discontinued. Long-term high-dose use or combination with other appetite suppressants may pose risks related to heart valve disease. Patients with cardiovascular disease, hypertension, hyperthyroidism, glaucoma, severe anxiety conditions, or a history of substance abuse should not take this medication. Children under 16 years of age, pregnant women, and patients with certain genetic disorders should also not use this medication. Patients with diabetes may require dosage adjustment of insulin while taking this medication. Caution should be exercised during driving or operating hazardous machinery while on medication; the risk of side effects is increased when taken with alcohol. In case of overdose, severe anxiety, coma, seizures, abnormal blood pressure, gastrointestinal symptoms may occur, requiring immediate emergency treatment. This medication should be kept out of reach of children and should be used cautiously due to potential dependency and abuse as it is classified as a controlled substance. Long-term use may lead to mental abnormalities or severe side effects, so it should be taken according to physician's instructions.

Primary pulmonary hypertension, valvular heart disease with regurgitation, palpitations, tachycardia, increased blood pressure, hyperexcitability, anxiety, dizziness, insomnia, discomfort, euphoria, tremors, headaches, psychotic seizures, thirst, unpleasant taste, diarrhea, constipation, other gastrointestinal disturbances, urticaria, erectile dysfunction, changes in sexual drive, anxiety, stupor, paradoxical reactions, increased respiration, confusion, hallucinations, aggression, panic state, convulsions in case of fatal overdose, coma, arrhythmia, hypertension or hypotension, circulatory shock, nausea, vomiting, abdominal pain, severe skin diseases, irritability, hyperfunction, personality changes, and schizophrenia-like psychiatric disorders

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. The storage temperature should be kept at room temperature between 1 degree and 30 degrees Celsius to maintain the medication's effectiveness.

Appearance

White round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle